Lecture 7 (Hem/oncology)-Exam 4 Flashcards
- What is MCV? What is small and large?
- What is MCHC? What is hypo/hyperchromic?
- WHat is MCH?
- What is RDW?
HEMOCHROMATOSIS
* What is it?
* What are risk factors?
* What are s/s?
- Iron Overload
- Risk factors: severe hemoglobinopathies, hematological malignancies, sideroblastic anemias, & multiple RBC transfusions
- Signs/symptoms: lethargy, hepatomegaly, hepatic cirrhosis, arthropathy/arthritis, diabetes mellitus, heart disease, hypogonadism
HEMOCHROMATOSIS
* What are the labs?
* What is the imaging/diagnostics?
* What is the txt?
- Labs: serum ferritin level significantly elevated, transferrin saturation elevated, and liver enzymes elevated
- Imaging/diagnostics: MRI/MRE of liver and liver biopsy
- Treatment: iron chelation agents (ie IV deferoxamine or PO deferasirox) & supportive treatment of damaged organs
THALASSEMIAS
* Defect in what?
* What is beta thalassemia? Who is it mc in?
* What is alpha thalassemia? Who is it mc in?
Defect in the alpha or beta chains of adult hemoglobin
* Beta thalassemia – defect of beta globin chains; low beta chains-> African, Mediterranean descent MC
* Alpha thalassemia - defect of alpha globin chains; low alpha chains->Middle East, North Africa, Southeast Asia descent MC
THALASSEMIAS
* Imbalance of what?
* Decreased what?
- Imbalance of alpha and beta chain production
- Decreased RBC survival and short RBC lifespan
Hemoglobin:
* What is it?
* Normal hemoglobin made up of what? What does it do?
- Oxygen carrying component of RBC
- Normal hemoglobin made of 2 alpha and 2 beta globin chains
- Each globin chain binds oxygen molecule
Beta thalassemia
* What are the chains like?
- Two normal alpha chains
- Partial (B+) or complete (B) beta globin deficiency
BETA THALASSEMIA
* What mutation?
* Dominant or recessive?
* Reduced or absent what?
* Increased or unmatched what? What does it cause?
Point mutation on chromosome 11
Autosomal recessive
* Two mutated genes required to cause severe disease
Reduced or absent beta globin chain synthesis
Increased, unmatched alpha chains
* Clump together forming inclusion bodies
* Damage RBC cell membranes
BETA THALASSEMIA
* What does deficiency of beta globin chains lead to?
Increased free alpha globin chains
* Clump together and form inclusion bodies
* Damage RBC cell membrane causing
* Hemolysis – RBC destroyed in bone marrow
* Extravascular hemolysis – RBC destroyed in spleen
Beta thalassemia
* Hemolysis leads to what?
- Hemoglobin spillage directly into plasma
- Hypoxia
Beta thalassemia-> hemolysis
* Hemoglobin spillage directly into plasma. Heme gets recycled to where (2)
* Hypoxia increases what? What is enlarged?
Beta thalassemia-hemolysis
* What is ineffective?
Ineffective erythropoiesis, chronic anemia, hypoxia cause increased iron absorption from duodenum
* Worsens hemochromatosis
Hemochromatosis
* What are the different areas?
- Cardiac (arrhythmias, pericarditis)
- Liver (cirrhosis)
- Endocrine (growth retardation, thyroid disorders, diabetes mellitus)
Beta thalassemia:
* Minor: What is the genetic mutation and what are the symptoms?
Beta Thalassemia
* Intermedia: what is the genetic mutation? What are the sx?
Beta Thalassemia
* Major: what is the genetic mutation? What are the sx?
transfusion dependent beta thalassemia
* What are the indications for transfusion? (3)
* What is the timing?
* What are the goals (3)?
Iron chelation therapy (ICT)
* Prevents accumulation of what?
* Remove what? (2)
* Initiation? What are the indications (ferritin levels and liver iron concentration)?
Iron absorption
* How is heme iron absorbed?
* How is non heme iron absorbed?
* Once absorbed Fe2 is stored by what?
* Once needed-what happens?
What are the typical sxs of anemia? What are the iron deficiency sxs?
Iron deficiency anemia - treatment
* What is first line?
* What is second line?
* What is for unstable patients?
First-line:
* oral iron replacement (stable patients)
Second-line:
* parenteral iron replacement (stable patients)
Packed RBC transfusion (unstable patients)
* Reserved for severe anemia (< 7 gm/dL) with symptoms
* Menstruating woman
* Rectal bleeding
Oral iron supplements: General considerations
* Different amounts of what?
* Variable what?
* Best absorption when?
* Avoid taking with what?
* What is common about the treatment?
- Different amounts of elemental iron with each iron salt
- Variable absorption – improved with acidic environment (Vit C?)
- Best absorption when taken on empty stomach – most patients cannot tolerate
- Slow-release, enteric-coated tablets generally not effective
- Avoid taking with medications that decrease absorption
- Treatment failure common – noncompliance due to intolerance
Iron replacement PO
Avoid taking with medications that decrease absorption? (3)
- Al, Mg, Ca containing antacids
- Antihistamines
- Proton pump inhibitors
Ferrous sulfate:
* What is the dose?
* What are the adverse effects?
* What are the CI?
IV iron replacement
* What are the indications? (4)
* Various formulas exist for determining what?
* Specific administration recommendations vary by what?
* _ efficacy
IV iron replacement: LMW iron dextran
* What is the disadvange and benefit?
Anemia of chronic disease (inflammation):
* What will chronic renal disease have?
* What will chronic inflammation have? What are different causes of chronic inflammation.
* What will be elevated and low?
* What is the txt?
Erythropoietin
* How does erytrohopietin work?
Recombinant erythropoietin (EPO)
* What are Erythropoietin stimulating agents (ESAs)? What are two examples?
* What is the indication?
Erythropoietin stimulating agents (ESAs) are recombinant EPO produced pharmacologically via recombinant DNA technology
* epoetin alfa (Procrit)
* darbepoetin (Aranesp)
Indication: anemia from CKD or malignancies with hemoglobin < 10 g/dL
EPO dosing:
* CKD:
* Chemo related anemia:
* Surgery associated transfusion reduction: ⭐️
- CKD: 50 to 100 units/kg IV or SC three days/week
- Chemo-related anemia: Start with 40,000 units subcutaneously every week or 150 units/kg/dose subcutaneously three times weekly
- Surgery-associated transfusion reduction: 300 units/kg/dose subcutaneously daily for 15 days before surgery